Last 12 months
Inside the activity.
3 purchase rows · 20 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 3 |
| Dec 2025 | 2 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 4 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 4 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 4 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 09, 2022 Filed Jun 10, 2022 20:22 UTC |
Casdin EliDirector
|
GrantStock Option (right to buy) · Derivative | 19,872 | $0.00 Strike: $8.56 | $0.00 |
DisclosureSEC source: 0001062993-22-014655 · form4.xml · derivative · entry 1 Casdin Eli · CIK 0001534264 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,872 Underlying: Common Stock · 19,872 shares Expires 2032-06-09 F1 · derivative.exercise_date: The option vests on the earlier of (a) June 9, 2023, or (b) the next annual meeting of stockholders, in each case subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| January 31, 2022 Filed Feb 2, 2022 21:31 UTC |
Versant Venture Capital VI, L.P.10% owner
Versant Ventures VI GP, L.P.10% owner
Versant Ventures VI GP-GP, LLC10% owner
Versant Vantage II, L.P.10% owner
Versant Vantage II GP, L.P.10% owner
Versant Vantage II GP-GP, LLC10% owner
|
OtherCommon Stock | 178,996 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-004169 · doc4.xml · nonDerivative · entry 1 Versant Venture Capital VI, L.P. · CIK 0001687880 · 10% owner Versant Ventures VI GP, L.P. · CIK 0001777654 · 10% owner Versant Ventures VI GP-GP, LLC · CIK 0001777652 · 10% owner Versant Vantage II, L.P. · CIK 0001832235 · 10% owner Versant Vantage II GP, L.P. · CIK 0001839790 · 10% owner Versant Vantage II GP-GP, LLC · CIK 0001839789 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,366,814 F1 · kind: Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Venture Capital VI, L.P. ("Versant VI") to its limited partners. F2 · ownership.direct: The reportable securities are owned directly by Versant VI. Versant Ventures VI GP, L.P. ("Versant Ventures VI GP") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC ("Versant Ventures VI GP-GP") is the general partner of Versant Ventures VI GP. Versant Ventures VI GP and Versant Ventures VI GP-GP may be deemed to indirectly beneficially own the shares beneficially owned by Versant VI, but disclaim beneficial ownership except to the extent of their pecuniary interest therein. Read SEC document |
| January 25, 2022 Filed Jan 27, 2022 21:51 UTC |
Diem Michael CraigChief Business Officer
|
GrantStock Option (right to buy) · Derivative | 105,000 | $0.00 Strike: $13.15 | $0.00 |
DisclosureSEC source: 0001062993-22-001691 · form4.xml · derivative · entry 1 Diem Michael Craig · CIK 0001497624 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,000 Underlying: Common Stock · 105,000 shares Expires 2032-01-25 F1 · derivative.exercise_date: The option vests 25% on January 25, 2023, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| January 25, 2022 Filed Jan 27, 2022 21:51 UTC |
Farid AdrienneChief Operations Officer
|
GrantStock Option (right to buy) · Derivative | 105,000 | $0.00 Strike: $13.15 | $0.00 |
DisclosureSEC source: 0001062993-22-001689 · form4.xml · derivative · entry 1 Farid Adrienne · CIK 0001867310 · Chief Operations Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,000 Underlying: Common Stock · 105,000 shares Expires 2032-01-25 F1 · derivative.exercise_date: The option vests 25% on January 25, 2023, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| January 25, 2022 Filed Jan 27, 2022 21:50 UTC |
Borges LuisChief Scientific Officer
|
GrantStock Option (right to buy) · Derivative | 105,000 | $0.00 Strike: $13.15 | $0.00 |
DisclosureSEC source: 0001062993-22-001688 · form4.xml · derivative · entry 1 Borges Luis · CIK 0001684015 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,000 Underlying: Common Stock · 105,000 shares Expires 2032-01-25 F1 · derivative.exercise_date: The option vests 25% on January 25, 2023, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| January 25, 2022 Filed Jan 27, 2022 21:50 UTC |
Levitsky HyamPresident of R&D
|
GrantStock Option (right to buy) · Derivative | 105,000 | $0.00 Strike: $13.15 | $0.00 |
DisclosureSEC source: 0001062993-22-001687 · form4.xml · derivative · entry 1 Levitsky Hyam · CIK 0001375792 · President of R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,000 Underlying: Common Stock · 105,000 shares Expires 2032-01-25 F1 · derivative.exercise_date: The option vests 25% on January 25, 2023, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| January 25, 2022 Filed Jan 27, 2022 21:50 UTC |
Russotti GregoryChief Technology Officer
|
GrantStock Option (right to buy) · Derivative | 105,000 | $0.00 Strike: $13.15 | $0.00 |
DisclosureSEC source: 0001062993-22-001686 · form4.xml · derivative · entry 1 Russotti Gregory · CIK 0001867305 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,000 Underlying: Common Stock · 105,000 shares Expires 2032-01-25 F1 · derivative.exercise_date: The option vests 25% on January 25, 2023, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| January 25, 2022 Filed Jan 27, 2022 21:49 UTC |
Flores OsvaldoChief Executive Officer
|
GrantStock Option (right to buy) · Derivative | 315,000 | $0.00 Strike: $13.15 | $0.00 |
DisclosureSEC source: 0001062993-22-001685 · form4.xml · derivative · entry 1 Flores Osvaldo · CIK 0001867301 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 315,000 Underlying: Common Stock · 315,000 shares Expires 2032-01-25 F1 · derivative.exercise_date: The option vests 25% on January 25, 2023, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| January 25, 2022 Filed Jan 27, 2022 21:49 UTC |
Carr DouglasVP of Finance and Operations
|
GrantStock Option (right to buy) · Derivative | 35,000 | $0.00 Strike: $13.15 | $0.00 |
DisclosureSEC source: 0001062993-22-001684 · form4.xml · derivative · entry 1 Carr Douglas · CIK 0001867173 · VP of Finance and Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2032-01-25 F1 · derivative.exercise_date: The option vests 25% on January 25, 2023, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| December 23, 2021 Filed Dec 28, 2021 21:46 UTC |
Versant Venture Capital VI, L.P.10% owner
Versant Ventures VI GP, L.P.10% owner
Versant Ventures VI GP-GP, LLC10% owner
Versant Vantage II, L.P.10% owner
Versant Vantage II GP, L.P.10% owner
Versant Vantage II GP-GP, LLC10% owner
|
OtherCommon Stock | 371,004 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-049938 · doc4.xml · nonDerivative · entry 1 Versant Venture Capital VI, L.P. · CIK 0001687880 · 10% owner Versant Ventures VI GP, L.P. · CIK 0001777654 · 10% owner Versant Ventures VI GP-GP, LLC · CIK 0001777652 · 10% owner Versant Vantage II, L.P. · CIK 0001832235 · 10% owner Versant Vantage II GP, L.P. · CIK 0001839790 · 10% owner Versant Vantage II GP-GP, LLC · CIK 0001839789 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,545,810 F1 · kind: Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Venture Capital VI, L.P. ("Versant VI") to its limited partners pursuant to a Rule 10b5-1 trading plan. F2 · ownership.direct: The reportable securities are owned directly by Versant VI. Versant Ventures VI GP, L.P. ("Versant Ventures VI GP") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC ("Versant Ventures VI GP-GP") is the general partner of Versant Ventures VI GP. Versant Ventures VI GP and Versant Ventures VI GP-GP may be deemed to indirectly beneficially own the shares beneficially owned by Versant VI, but disclaim beneficial ownership except to the extent of their pecuniary interest therein. Read SEC document |
| June 22, 2021 Filed Jun 22, 2021 20:31 UTC |
Casdin EliDirector
|
ConversionSeries C Preferred Stock · Derivative | 6,180,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-21-000569 · edgar.xml · derivative · entry 3 Casdin Eli · CIK 0001534264 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 2,456,380 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Shares of Series C Preferred Stock automatically converted into shares of Common Stock at a 2.5161-for-1 conversion rate immediately prior to the closing of the Issuer's initial public offering and have no expiration date. F1 · derivative.exercise_date: Shares of Series C Preferred Stock automatically converted into shares of Common Stock at a 2.5161-for-1 conversion rate immediately prior to the closing of the Issuer's initial public offering and have no expiration date. F1 · derivative.expiration_date: Shares of Series C Preferred Stock automatically converted into shares of Common Stock at a 2.5161-for-1 conversion rate immediately prior to the closing of the Issuer's initial public offering and have no expiration date. F1 · derivative.underlying_shares: Shares of Series C Preferred Stock automatically converted into shares of Common Stock at a 2.5161-for-1 conversion rate immediately prior to the closing of the Issuer's initial public offering and have no expiration date. F2 · ownership.nature: Consists of (i) 1,228,190 shares of Common Stock directly held by Casdin Partners Master Fund, L.P. and (ii) 1,228,190 shares of Common Stock directly held by Casdin Private Growth Equity Fund, L.P. The securities owned directly by Casdin Partners Master Fund, L.P. may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC, the investment adviser to Casdin Partners Master Fund, L.P., (ii) Casdin Partners GP, LLC, the general partner of Casdin Partners Master Fund LP, and (iii) Eli Casdin, the managing member of Casdin Capital, LLC and Casdin Partners GP, LLC. Each of Casdin Capital, LLC, Casdin Partners GP, LLC and Eli Casdin disclaims beneficial ownership of such securities except to the extent of their respective pecuniary interest therein. The securities owned directly by Casdin Private Growth Equity Fund, L.P. may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC, the investment adviser to Casdin Private Growth Equity Fund, L.P., (ii) Casdin Private Growth Equity Fund GP, LLC, the general partner of Casdin Private Growth Equity Fund, L.P., and (iii) Eli Casdin, the managing member of Casdin Capital, LLC and Casdin Private Growth Equity Fund GP, LLC. Each of Casdin Capital, LLC, Casdin Private Growth Equity Fund GP, LLC and Eli Casdin disclaims beneficial ownership of such securities except to the extent of their respective pecuniary interest therein. Read SEC document |
| June 22, 2021 Filed Jun 22, 2021 20:31 UTC |
Casdin EliDirector
|
PurchaseCommon Stock | 750,000 | $20.00 | $15,000,000.00 |
DisclosureSEC source: 0001192482-21-000569 · edgar.xml · nonDerivative · entry 2 Casdin Eli · CIK 0001534264 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 3,206,380 F3 · ownership.nature: The shares reflected are beneficially owned by Casdin Partners Master Fund, L.P.. Such securities are owned directly by Casdin Partners Master Fund, L.P. and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC, the investment adviser to Casdin Partners Master Fund, L.P., (ii) Casdin Partners GP, LLC, the general partner of Casdin Partners Master Fund LP, and (iii) Eli Casdin, the managing member of Casdin Capital, LLC and Casdin Partners GP, LLC. Each of Casdin Capital, LLC, Casdin Partners GP, LLC and Eli Casdin disclaims beneficial ownership of such securities except to the extent of their respective pecuniary interest therein. Read SEC document |
| June 22, 2021 Filed Jun 22, 2021 20:31 UTC |
Casdin EliDirector
|
ConversionCommon Stock | 2,456,380 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001192482-21-000569 · edgar.xml · nonDerivative · entry 1 Casdin Eli · CIK 0001534264 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,456,380 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Shares of Series C Preferred Stock automatically converted into shares of Common Stock at a 2.5161-for-1 conversion rate immediately prior to the closing of the Issuer's initial public offering and have no expiration date. F2 · ownership.nature: Consists of (i) 1,228,190 shares of Common Stock directly held by Casdin Partners Master Fund, L.P. and (ii) 1,228,190 shares of Common Stock directly held by Casdin Private Growth Equity Fund, L.P. The securities owned directly by Casdin Partners Master Fund, L.P. may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC, the investment adviser to Casdin Partners Master Fund, L.P., (ii) Casdin Partners GP, LLC, the general partner of Casdin Partners Master Fund LP, and (iii) Eli Casdin, the managing member of Casdin Capital, LLC and Casdin Partners GP, LLC. Each of Casdin Capital, LLC, Casdin Partners GP, LLC and Eli Casdin disclaims beneficial ownership of such securities except to the extent of their respective pecuniary interest therein. The securities owned directly by Casdin Private Growth Equity Fund, L.P. may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC, the investment adviser to Casdin Private Growth Equity Fund, L.P., (ii) Casdin Private Growth Equity Fund GP, LLC, the general partner of Casdin Private Growth Equity Fund, L.P., and (iii) Eli Casdin, the managing member of Casdin Capital, LLC and Casdin Private Growth Equity Fund GP, LLC. Each of Casdin Capital, LLC, Casdin Private Growth Equity Fund GP, LLC and Eli Casdin disclaims beneficial ownership of such securities except to the extent of their respective pecuniary interest therein. Read SEC document |
| June 22, 2021 Filed Jun 23, 2021 16:41 UTC |
BAYER AKTIENGESELLSCHAFT10% owner
Bayer World Investments B.V.10% owner
|
ConversionSeries C Preferred Stock · Derivative | 3,862,813 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-042752 · doc4.xml · derivative · entry 5 BAYER AKTIENGESELLSCHAFT · CIK 0001144145 · 10% owner Bayer World Investments B.V. · CIK 0001820027 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,535,238 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Shares of Series C Preferred Stock converted into shares of Common Stock at the closing of the Issuer's initial public offering at a 2.5161-for-1 conversion ratio for no consideration, and had no expiration date. F3 · price: Shares of Series C Preferred Stock converted into shares of Common Stock at the closing of the Issuer's initial public offering at a 2.5161-for-1 conversion ratio for no consideration, and had no expiration date. F3 · derivative.exercise_date: Shares of Series C Preferred Stock converted into shares of Common Stock at the closing of the Issuer's initial public offering at a 2.5161-for-1 conversion ratio for no consideration, and had no expiration date. F3 · derivative.expiration_date: Shares of Series C Preferred Stock converted into shares of Common Stock at the closing of the Issuer's initial public offering at a 2.5161-for-1 conversion ratio for no consideration, and had no expiration date. F3 · derivative.underlying_shares: Shares of Series C Preferred Stock converted into shares of Common Stock at the closing of the Issuer's initial public offering at a 2.5161-for-1 conversion ratio for no consideration, and had no expiration date. F2 · ownership.direct: The securities reported are held directly by Bayer World Investments B.V., a Dutch private limited company, which is an indirect, wholly owned subsidiary of Bayer Aktiengesellschaft, a German stock corporation. Accordingly, Bayer Aktiengesellschaft may be deemed to be an indirect beneficial owner of the shares beneficially owned directly by Bayer World Investments B.V. Read SEC document |
| June 22, 2021 Filed Jun 23, 2021 16:41 UTC |
BAYER AKTIENGESELLSCHAFT10% owner
Bayer World Investments B.V.10% owner
|
ConversionSeries B Preferred Stock · Derivative | 26,143,790 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-042752 · doc4.xml · derivative · entry 4 BAYER AKTIENGESELLSCHAFT · CIK 0001144145 · 10% owner Bayer World Investments B.V. · CIK 0001820027 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,390,600 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Shares of Series B Preferred Stock converted into shares of Common Stock at the closing of the Issuer's initial public offering at a 2.5161-for-1 conversion ratio for no consideration, and had no expiration date. F1 · price: Shares of Series B Preferred Stock converted into shares of Common Stock at the closing of the Issuer's initial public offering at a 2.5161-for-1 conversion ratio for no consideration, and had no expiration date. F1 · derivative.exercise_date: Shares of Series B Preferred Stock converted into shares of Common Stock at the closing of the Issuer's initial public offering at a 2.5161-for-1 conversion ratio for no consideration, and had no expiration date. F1 · derivative.expiration_date: Shares of Series B Preferred Stock converted into shares of Common Stock at the closing of the Issuer's initial public offering at a 2.5161-for-1 conversion ratio for no consideration, and had no expiration date. F1 · derivative.underlying_shares: Shares of Series B Preferred Stock converted into shares of Common Stock at the closing of the Issuer's initial public offering at a 2.5161-for-1 conversion ratio for no consideration, and had no expiration date. F2 · ownership.direct: The securities reported are held directly by Bayer World Investments B.V., a Dutch private limited company, which is an indirect, wholly owned subsidiary of Bayer Aktiengesellschaft, a German stock corporation. Accordingly, Bayer Aktiengesellschaft may be deemed to be an indirect beneficial owner of the shares beneficially owned directly by Bayer World Investments B.V. Read SEC document |
| June 22, 2021 Filed Jun 23, 2021 16:41 UTC |
BAYER AKTIENGESELLSCHAFT10% owner
Bayer World Investments B.V.10% owner
|
PurchaseCommon Stock | 750,000 | $20.00 | $15,000,000.00 |
DisclosureSEC source: 0001209191-21-042752 · doc4.xml · nonDerivative · entry 3 BAYER AKTIENGESELLSCHAFT · CIK 0001144145 · 10% owner Bayer World Investments B.V. · CIK 0001820027 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,675,838 F2 · ownership.direct: The securities reported are held directly by Bayer World Investments B.V., a Dutch private limited company, which is an indirect, wholly owned subsidiary of Bayer Aktiengesellschaft, a German stock corporation. Accordingly, Bayer Aktiengesellschaft may be deemed to be an indirect beneficial owner of the shares beneficially owned directly by Bayer World Investments B.V. Read SEC document |
| June 22, 2021 Filed Jun 23, 2021 16:41 UTC |
BAYER AKTIENGESELLSCHAFT10% owner
Bayer World Investments B.V.10% owner
|
ConversionCommon Stock | 1,535,238 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-042752 · doc4.xml · nonDerivative · entry 2 BAYER AKTIENGESELLSCHAFT · CIK 0001144145 · 10% owner Bayer World Investments B.V. · CIK 0001820027 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,925,838 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Shares of Series C Preferred Stock converted into shares of Common Stock at the closing of the Issuer's initial public offering at a 2.5161-for-1 conversion ratio for no consideration, and had no expiration date. F2 · ownership.direct: The securities reported are held directly by Bayer World Investments B.V., a Dutch private limited company, which is an indirect, wholly owned subsidiary of Bayer Aktiengesellschaft, a German stock corporation. Accordingly, Bayer Aktiengesellschaft may be deemed to be an indirect beneficial owner of the shares beneficially owned directly by Bayer World Investments B.V. Read SEC document |
| June 22, 2021 Filed Jun 23, 2021 16:41 UTC |
BAYER AKTIENGESELLSCHAFT10% owner
Bayer World Investments B.V.10% owner
|
ConversionCommon Stock | 10,390,600 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-042752 · doc4.xml · nonDerivative · entry 1 BAYER AKTIENGESELLSCHAFT · CIK 0001144145 · 10% owner Bayer World Investments B.V. · CIK 0001820027 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,390,600 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Shares of Series B Preferred Stock converted into shares of Common Stock at the closing of the Issuer's initial public offering at a 2.5161-for-1 conversion ratio for no consideration, and had no expiration date. F2 · ownership.direct: The securities reported are held directly by Bayer World Investments B.V., a Dutch private limited company, which is an indirect, wholly owned subsidiary of Bayer Aktiengesellschaft, a German stock corporation. Accordingly, Bayer Aktiengesellschaft may be deemed to be an indirect beneficial owner of the shares beneficially owned directly by Bayer World Investments B.V. Read SEC document |
| June 22, 2021 Filed Jun 23, 2021 21:00 UTC |
FUJIFILM Cellular Dynamics, Inc.10% owner
FUJIFILM Corp10% owner
FUJIFILM Holdings America Corp10% owner
FUJIFILM Holdings Corp10% owner
|
ConversionSeries A Convertible Preferred Stock · Derivative | 10,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-21-006870 · ownership.xml · derivative · entry 2 FUJIFILM Cellular Dynamics, Inc. · CIK 0001868056 · 10% owner FUJIFILM Corp · CIK 0001637891 · 10% owner FUJIFILM Holdings America Corp · CIK 0001637886 · 10% owner FUJIFILM Holdings Corp · CIK 0001537075 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,974,404 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: FUJIFILM Cellular Dynamics, Inc. held 10,000,000 shares of the issuer's Series A Convertible Preferred Stock. The Series A Convertible Preferred Stock was immediately convertible into shares of the issuer's common stock and had no expiration date. On June 22, 2021, the 10,000,000 shares of Series A Convertible Preferred Stock automatically converted into 3,974,404 shares of the issuer's common stock upon the closing of the issuer's initial public offering. F1 · derivative.exercise_date: FUJIFILM Cellular Dynamics, Inc. held 10,000,000 shares of the issuer's Series A Convertible Preferred Stock. The Series A Convertible Preferred Stock was immediately convertible into shares of the issuer's common stock and had no expiration date. On June 22, 2021, the 10,000,000 shares of Series A Convertible Preferred Stock automatically converted into 3,974,404 shares of the issuer's common stock upon the closing of the issuer's initial public offering. F1 · derivative.expiration_date: FUJIFILM Cellular Dynamics, Inc. held 10,000,000 shares of the issuer's Series A Convertible Preferred Stock. The Series A Convertible Preferred Stock was immediately convertible into shares of the issuer's common stock and had no expiration date. On June 22, 2021, the 10,000,000 shares of Series A Convertible Preferred Stock automatically converted into 3,974,404 shares of the issuer's common stock upon the closing of the issuer's initial public offering. F1 · derivative.underlying_shares: FUJIFILM Cellular Dynamics, Inc. held 10,000,000 shares of the issuer's Series A Convertible Preferred Stock. The Series A Convertible Preferred Stock was immediately convertible into shares of the issuer's common stock and had no expiration date. On June 22, 2021, the 10,000,000 shares of Series A Convertible Preferred Stock automatically converted into 3,974,404 shares of the issuer's common stock upon the closing of the issuer's initial public offering. F2 · ownership.direct: FUJIFILM Cellular Dynamics, Inc. is the direct owner of the reported securities. FUJIFILM Cellular Dynamics, Inc. is a wholly owned subsidiary of FUJIFILM Holdings America Corporation; FUJIFILM Holdings America Corporation is a wholly owned subsidiary of FUJIFILM Corporation; and FUJIFILM Corporation is a wholly owned subsidiary of FUJIFILM Holdings Corporation. Accordingly, each of FUJIFILM Holdings America Corporation, FUJIFILM Corporation and FUJIFILM Holdings Corporation beneficially owns the reported securities indirectly. Read SEC document |
| June 22, 2021 Filed Jun 23, 2021 21:00 UTC |
FUJIFILM Cellular Dynamics, Inc.10% owner
FUJIFILM Corp10% owner
FUJIFILM Holdings America Corp10% owner
FUJIFILM Holdings Corp10% owner
|
ConversionCommon Stock | 3,974,404 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001214659-21-006870 · ownership.xml · nonDerivative · entry 1 FUJIFILM Cellular Dynamics, Inc. · CIK 0001868056 · 10% owner FUJIFILM Corp · CIK 0001637891 · 10% owner FUJIFILM Holdings America Corp · CIK 0001637886 · 10% owner FUJIFILM Holdings Corp · CIK 0001537075 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,955,207 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: FUJIFILM Cellular Dynamics, Inc. held 10,000,000 shares of the issuer's Series A Convertible Preferred Stock. The Series A Convertible Preferred Stock was immediately convertible into shares of the issuer's common stock and had no expiration date. On June 22, 2021, the 10,000,000 shares of Series A Convertible Preferred Stock automatically converted into 3,974,404 shares of the issuer's common stock upon the closing of the issuer's initial public offering. F2 · ownership.direct: FUJIFILM Cellular Dynamics, Inc. is the direct owner of the reported securities. FUJIFILM Cellular Dynamics, Inc. is a wholly owned subsidiary of FUJIFILM Holdings America Corporation; FUJIFILM Holdings America Corporation is a wholly owned subsidiary of FUJIFILM Corporation; and FUJIFILM Corporation is a wholly owned subsidiary of FUJIFILM Holdings Corporation. Accordingly, each of FUJIFILM Holdings America Corporation, FUJIFILM Corporation and FUJIFILM Holdings Corporation beneficially owns the reported securities indirectly. Read SEC document |
| June 22, 2021 Filed Jun 23, 2021 20:30 UTC |
Versant Venture Capital VI, L.P.10% owner
Versant Ventures VI GP, L.P.10% owner
Versant Ventures VI GP-GP, LLC10% owner
Versant Vantage II, L.P.10% owner
Versant Vantage II GP, L.P.10% owner
Versant Vantage II GP-GP, LLC10% owner
|
ConversionSeries C Preferred Stock · Derivative | 1,545,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-084643 · tm2120529-1_4seq1.xml · derivative · entry 5 Versant Venture Capital VI, L.P. · CIK 0001687880 · 10% owner Versant Ventures VI GP, L.P. · CIK 0001777654 · 10% owner Versant Ventures VI GP-GP, LLC · CIK 0001777652 · 10% owner Versant Vantage II, L.P. · CIK 0001832235 · 10% owner Versant Vantage II GP, L.P. · CIK 0001839790 · 10% owner Versant Vantage II GP-GP, LLC · CIK 0001839789 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 614,095 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Shares of Series C Preferred Stock automatically converted into shares of Common Stock at a 2.5161-for-1 conversion rate immediately prior to the closing of the Issuer's initial public offering and have no expiration date. F3 · derivative.exercise_date: Shares of Series C Preferred Stock automatically converted into shares of Common Stock at a 2.5161-for-1 conversion rate immediately prior to the closing of the Issuer's initial public offering and have no expiration date. F3 · derivative.expiration_date: Shares of Series C Preferred Stock automatically converted into shares of Common Stock at a 2.5161-for-1 conversion rate immediately prior to the closing of the Issuer's initial public offering and have no expiration date. F3 · derivative.underlying_shares: Shares of Series C Preferred Stock automatically converted into shares of Common Stock at a 2.5161-for-1 conversion rate immediately prior to the closing of the Issuer's initial public offering and have no expiration date. F4 · ownership.nature: The reportable securities are owned by Versant Vantage II, L.P. ("Versant Vantage II''). Versant Vantage II GP, L.P. ("Versant Vantage II GP") is the general partner of Versant Vantage II, and Versant Vantage II GP-GP, LLC ("Versant Vantage II GP-GP") is the general partner of Versant Vantage II GP. Versant Vantage II GP and Versant Vantage II GP-GP may be deemed to indirectly beneficially own the shares beneficially owned by Versant Vantage II, but disclaim beneficial ownership except to the extent of their pecuniary interest therein. Read SEC document |
| June 22, 2021 Filed Jun 23, 2021 20:30 UTC |
Versant Venture Capital VI, L.P.10% owner
Versant Ventures VI GP, L.P.10% owner
Versant Ventures VI GP-GP, LLC10% owner
Versant Vantage II, L.P.10% owner
Versant Vantage II GP, L.P.10% owner
Versant Vantage II GP-GP, LLC10% owner
|
ConversionSeries A Preferred Stock · Derivative | 25,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-084643 · tm2120529-1_4seq1.xml · derivative · entry 4 Versant Venture Capital VI, L.P. · CIK 0001687880 · 10% owner Versant Ventures VI GP, L.P. · CIK 0001777654 · 10% owner Versant Ventures VI GP-GP, LLC · CIK 0001777652 · 10% owner Versant Vantage II, L.P. · CIK 0001832235 · 10% owner Versant Vantage II GP, L.P. · CIK 0001839790 · 10% owner Versant Vantage II GP-GP, LLC · CIK 0001839789 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,936,011 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 2.5161-for-1 conversion rate immediately prior to the closing of the Issuer's initial public offering and have no expiration date. F1 · derivative.exercise_date: Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 2.5161-for-1 conversion rate immediately prior to the closing of the Issuer's initial public offering and have no expiration date. F1 · derivative.expiration_date: Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 2.5161-for-1 conversion rate immediately prior to the closing of the Issuer's initial public offering and have no expiration date. F1 · derivative.underlying_shares: Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 2.5161-for-1 conversion rate immediately prior to the closing of the Issuer's initial public offering and have no expiration date. F2 · ownership.direct: The reportable securities are owned directly by Versant Venture Capital VI, L.P. ("Versant VI"). Versant Ventures VI GP, L.P. ("Versant Ventures VI GP") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC ("Versant Ventures VI GP-GP") is the general partner of Versant Ventures VI GP. Versant Ventures VI GP and Versant Ventures VI GP-GP may be deemed to indirectly beneficially own the shares beneficially owned by Versant VI, but disclaim beneficial ownership except to the extent of their pecuniary interest therein. Read SEC document |
| June 22, 2021 Filed Jun 23, 2021 20:30 UTC |
Versant Venture Capital VI, L.P.10% owner
Versant Ventures VI GP, L.P.10% owner
Versant Ventures VI GP-GP, LLC10% owner
Versant Vantage II, L.P.10% owner
Versant Vantage II GP, L.P.10% owner
Versant Vantage II GP-GP, LLC10% owner
|
PurchaseCommon Stock | 100,000 | $20.00 | $2,000,000.00 |
DisclosureSEC source: 0001104659-21-084643 · tm2120529-1_4seq1.xml · nonDerivative · entry 3 Versant Venture Capital VI, L.P. · CIK 0001687880 · 10% owner Versant Ventures VI GP, L.P. · CIK 0001777654 · 10% owner Versant Ventures VI GP-GP, LLC · CIK 0001777652 · 10% owner Versant Vantage II, L.P. · CIK 0001832235 · 10% owner Versant Vantage II GP, L.P. · CIK 0001839790 · 10% owner Versant Vantage II GP-GP, LLC · CIK 0001839789 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 714,095 F4 · ownership.nature: The reportable securities are owned by Versant Vantage II, L.P. ("Versant Vantage II''). Versant Vantage II GP, L.P. ("Versant Vantage II GP") is the general partner of Versant Vantage II, and Versant Vantage II GP-GP, LLC ("Versant Vantage II GP-GP") is the general partner of Versant Vantage II GP. Versant Vantage II GP and Versant Vantage II GP-GP may be deemed to indirectly beneficially own the shares beneficially owned by Versant Vantage II, but disclaim beneficial ownership except to the extent of their pecuniary interest therein. Read SEC document |
| June 22, 2021 Filed Jun 23, 2021 20:30 UTC |
Versant Venture Capital VI, L.P.10% owner
Versant Ventures VI GP, L.P.10% owner
Versant Ventures VI GP-GP, LLC10% owner
Versant Vantage II, L.P.10% owner
Versant Vantage II GP, L.P.10% owner
Versant Vantage II GP-GP, LLC10% owner
|
ConversionCommon Stock | 614,095 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-084643 · tm2120529-1_4seq1.xml · nonDerivative · entry 2 Versant Venture Capital VI, L.P. · CIK 0001687880 · 10% owner Versant Ventures VI GP, L.P. · CIK 0001777654 · 10% owner Versant Ventures VI GP-GP, LLC · CIK 0001777652 · 10% owner Versant Vantage II, L.P. · CIK 0001832235 · 10% owner Versant Vantage II GP, L.P. · CIK 0001839790 · 10% owner Versant Vantage II GP-GP, LLC · CIK 0001839789 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 614,095 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Shares of Series C Preferred Stock automatically converted into shares of Common Stock at a 2.5161-for-1 conversion rate immediately prior to the closing of the Issuer's initial public offering and have no expiration date. F4 · ownership.nature: The reportable securities are owned by Versant Vantage II, L.P. ("Versant Vantage II''). Versant Vantage II GP, L.P. ("Versant Vantage II GP") is the general partner of Versant Vantage II, and Versant Vantage II GP-GP, LLC ("Versant Vantage II GP-GP") is the general partner of Versant Vantage II GP. Versant Vantage II GP and Versant Vantage II GP-GP may be deemed to indirectly beneficially own the shares beneficially owned by Versant Vantage II, but disclaim beneficial ownership except to the extent of their pecuniary interest therein. Read SEC document |
| June 22, 2021 Filed Jun 23, 2021 20:30 UTC |
Versant Venture Capital VI, L.P.10% owner
Versant Ventures VI GP, L.P.10% owner
Versant Ventures VI GP-GP, LLC10% owner
Versant Vantage II, L.P.10% owner
Versant Vantage II GP, L.P.10% owner
Versant Vantage II GP-GP, LLC10% owner
|
ConversionCommon Stock | 9,936,011 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-084643 · tm2120529-1_4seq1.xml · nonDerivative · entry 1 Versant Venture Capital VI, L.P. · CIK 0001687880 · 10% owner Versant Ventures VI GP, L.P. · CIK 0001777654 · 10% owner Versant Ventures VI GP-GP, LLC · CIK 0001777652 · 10% owner Versant Vantage II, L.P. · CIK 0001832235 · 10% owner Versant Vantage II GP, L.P. · CIK 0001839790 · 10% owner Versant Vantage II GP-GP, LLC · CIK 0001839789 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,916,814 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Shares of Series A Preferred Stock automatically converted into shares of Common Stock at a 2.5161-for-1 conversion rate immediately prior to the closing of the Issuer's initial public offering and have no expiration date. F2 · ownership.direct: The reportable securities are owned directly by Versant Venture Capital VI, L.P. ("Versant VI"). Versant Ventures VI GP, L.P. ("Versant Ventures VI GP") is the general partner of Versant VI, and Versant Ventures VI GP-GP, LLC ("Versant Ventures VI GP-GP") is the general partner of Versant Ventures VI GP. Versant Ventures VI GP and Versant Ventures VI GP-GP may be deemed to indirectly beneficially own the shares beneficially owned by Versant VI, but disclaim beneficial ownership except to the extent of their pecuniary interest therein. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 20:33 UTC |
JIMENEZ JOSEPHDirector
|
GrantOption (right to buy) · Derivative | 19,872 | $0.00 Strike: $20.00 | $0.00 |
DisclosureSEC source: 0001192482-21-000561 · edgar.xml · derivative · entry 1 JIMENEZ JOSEPH · CIK 0001199095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,872 Underlying: Common Stock · 19,872 shares Expires 2031-06-17 F1 · derivative.exercise_date: The option vests on the earlier of (a) June 17, 2022 or (b) the next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 20:34 UTC |
Blackwell KimberlyDirector
|
GrantOption (right to buy) · Derivative | 19,872 | $0.00 Strike: $20.00 | $0.00 |
DisclosureSEC source: 0001192482-21-000562 · edgar.xml · derivative · entry 1 Blackwell Kimberly · CIK 0001816465 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,872 Underlying: Common Stock · 19,872 shares Expires 2031-06-17 F1 · derivative.exercise_date: The option vests on the earlier of (a) June 17, 2022 or (b) the next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 20:33 UTC |
Casdin EliDirector
|
Disposition to issuerOption (right to buy) · Derivative | 39,744 | $0.00 Strike: $20.00 | $0.00 |
DisclosureSEC source: 0001192482-21-000560 · edgar.xml · derivative · entry 1 Casdin Eli · CIK 0001534264 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,744 Underlying: Common Stock · 39,744 shares Expires 2031-06-17 F1 · derivative.exercise_date: The option vests in 36 equal monthly installments, subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 20:32 UTC |
BUTITTA CYNTHIA MDirector
|
GrantOption (right to buy) · Derivative | 19,872 | $0.00 Strike: $20.00 | $0.00 |
DisclosureSEC source: 0001192482-21-000559 · edgar.xml · derivative · entry 1 BUTITTA CYNTHIA M · CIK 0001222082 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,872 Underlying: Common Stock · 19,872 shares Expires 2031-06-17 F1 · derivative.exercise_date: The option vests on the earlier of (a) June 17, 2022 or (b) the next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 20:32 UTC |
Carlo RizzutoDirector
|
GrantOption (right to buy) · Derivative | 39,744 | $0.00 Strike: $20.00 | $0.00 |
DisclosureSEC source: 0001192482-21-000558 · edgar.xml · derivative · entry 1 Carlo Rizzuto · CIK 0001817033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,744 Underlying: Common Stock · 39,744 shares Expires 2031-06-17 F1 · derivative.exercise_date: The option vests in 36 equal monthly installments, subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 20:31 UTC |
Riva AlessandroDirector
|
GrantOption (right to buy) · Derivative | 19,872 | $0.00 Strike: $20.00 | $0.00 |
DisclosureSEC source: 0001192482-21-000557 · edgar.xml · derivative · entry 1 Riva Alessandro · CIK 0001867172 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,872 Underlying: Common Stock · 19,872 shares Expires 2031-06-17 F1 · derivative.exercise_date: The option vests on the earlier of (a) June 17, 2022 or (b) the next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.